Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D000450:Aldosterone / Q000627:therapeutic use; D001201:Ascites / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications*; D006349:Heart Valve Diseases / Q000473:pathology; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000150:complications*; D010243:Paralysis / Q000139:chemically induced* / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000473:pathology; D013148:Spironolactone / Q000009:adverse effects* / Q000627:therapeutic use
D013148:Spironolactone; D000450:Aldosterone; D005665:Furosemide; D000086:Acetazolamide